The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting SteNt Study: Head-to-head Comparison of Clinical Outcome After Implantation of Second Generation Drug-eluting Stents in a Real World Scenario.
Phase of Trial: Phase IV
Latest Information Update: 31 Aug 2016
At a glance
- Drugs Zotarolimus (Primary) ; Everolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms TWENTE
- 04 Sep 2013 Two-year results according to gender presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
- 09 Feb 2012 Results published in the Journal of the American College of Cardiology.
- 28 Aug 2010 During the first 16 months of study 1005 out of 1104 (91%) eligible patients were included - this represents 73% of the inclusion target, as reported in an abstract at ESC Congress 2010.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History